SPHERA FUNDS MANAGEMENT LTD. - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 62 filers reported holding IMMUNE DESIGN CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$567,000
-63.2%
103,000
-49.3%
0.14%
-42.6%
Q3 2016$1,539,000
+23.3%
203,000
+32.7%
0.25%
-22.5%
Q2 2016$1,248,000
-37.3%
153,0000.0%0.32%
-24.8%
Q1 2016$1,989,000
-35.3%
153,0000.0%0.43%
-4.2%
Q4 2015$3,072,000
+48.1%
153,000
-10.0%
0.45%
+69.8%
Q3 2015$2,074,000
-28.3%
170,000
+21.4%
0.26%
-6.4%
Q2 2015$2,891,000
+5.8%
140,000
+8.2%
0.28%
-0.4%
Q1 2015$2,732,000129,4400.28%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders